Limits...
Economic burden of asthma: a systematic review.

Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, FitzGerald JM - BMC Pulm Med (2009)

Bottom Line: It is also associated with the loss of future potential earnings related to both morbidity and mortality.Hospitalization and medications were found to be the most important cost driver of direct costs.Work and school loss accounted for the greatest percentage of indirect costs.

View Article: PubMed Central - HTML - PubMed

Affiliation: Centre for Clinical Epidemiology & Evaluation (C2E2), UBC, Vancouver, BC, Canada. Cbahadori@yahoo.ca

ABSTRACT

Background: Asthma is associated with enormous healthcare expenditures that include both direct and indirect costs. It is also associated with the loss of future potential earnings related to both morbidity and mortality. The objective of the study is to determine the burden of disease costs associated with asthma.

Methods: We performed a systematic search of MEDLINE, EMBASE, CINAHL, CDSR, OHE-HEED, and Web of Science Databases between 1966 and 2008.

Results: Sixty-eight studies met the inclusion criteria. Hospitalization and medications were found to be the most important cost driver of direct costs. Work and school loss accounted for the greatest percentage of indirect costs. The cost of asthma was correlated with comorbidities, age, and disease severity.

Conclusion: Despite the availability of effective preventive therapy, costs associated with asthma are increasing. Strategies including education of patients and physicians, and regular follow-up are required to reduce the economic burden of asthma.

Show MeSH

Related in: MedlinePlus

Results of systematic literature search.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC2698859&req=5

Figure 2: Results of systematic literature search.

Mentions: The primary literature search identified 2,976 citations. After removing duplicate citations we were left with 2,073 unique citations for screening. The manual screening of all 2,073 titles and abstracts yielded 307 articles that contained primary clinical data evaluating the cost of asthma. Of the 307 full articles retrieved and reviewed by the investigators, 68 met the inclusion criteria (Figure 2).


Economic burden of asthma: a systematic review.

Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, FitzGerald JM - BMC Pulm Med (2009)

Results of systematic literature search.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC2698859&req=5

Figure 2: Results of systematic literature search.
Mentions: The primary literature search identified 2,976 citations. After removing duplicate citations we were left with 2,073 unique citations for screening. The manual screening of all 2,073 titles and abstracts yielded 307 articles that contained primary clinical data evaluating the cost of asthma. Of the 307 full articles retrieved and reviewed by the investigators, 68 met the inclusion criteria (Figure 2).

Bottom Line: It is also associated with the loss of future potential earnings related to both morbidity and mortality.Hospitalization and medications were found to be the most important cost driver of direct costs.Work and school loss accounted for the greatest percentage of indirect costs.

View Article: PubMed Central - HTML - PubMed

Affiliation: Centre for Clinical Epidemiology & Evaluation (C2E2), UBC, Vancouver, BC, Canada. Cbahadori@yahoo.ca

ABSTRACT

Background: Asthma is associated with enormous healthcare expenditures that include both direct and indirect costs. It is also associated with the loss of future potential earnings related to both morbidity and mortality. The objective of the study is to determine the burden of disease costs associated with asthma.

Methods: We performed a systematic search of MEDLINE, EMBASE, CINAHL, CDSR, OHE-HEED, and Web of Science Databases between 1966 and 2008.

Results: Sixty-eight studies met the inclusion criteria. Hospitalization and medications were found to be the most important cost driver of direct costs. Work and school loss accounted for the greatest percentage of indirect costs. The cost of asthma was correlated with comorbidities, age, and disease severity.

Conclusion: Despite the availability of effective preventive therapy, costs associated with asthma are increasing. Strategies including education of patients and physicians, and regular follow-up are required to reduce the economic burden of asthma.

Show MeSH
Related in: MedlinePlus